ResearcherQingdao UniversityActive in the last 2 years
Qian Yu
Matched on ORCID iD 0000-0002-4862-3640; OpenAlex author ID A5114417902. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2024: 1 paper · 2025: 3 papers · 2026: 1 paper
Papers 5
- Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory facto… Co-author DOI 10.1038/s41392-025-02562-8↗
- hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217436↗
- Design of nano-delivery systems for pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.canlet.2025.218098↗
- HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.2174/1566523223666230720101531↗
- Hepatic Macrophage Migration Inhibitory Factor Promotes Pancreatic Cancer Liver Metastasis in NAFLD Co-author DOI 10.1101/2024.06.02.595997↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruining Gong · 5 shared papers, 2024–2026 · strength 1.09
- Paper HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma DOI 10.2174/1566523223666230720101531↗
- Paper hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.217436↗
- Paper Design of nano-delivery systems for pancreatic cancer immunotherapy. DOI 10.1016/j.canlet.2025.218098↗
- He Ren · 5 shared papers, 2024–2026 · strength 1.09
- Paper HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma DOI 10.2174/1566523223666230720101531↗
- Paper hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.217436↗
- Paper Design of nano-delivery systems for pancreatic cancer immunotherapy. DOI 10.1016/j.canlet.2025.218098↗
- Ashok Kumar Saluja · 3 shared papers, 2024–2026 · strength 0.59
- Paper hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.217436↗
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8↗
- Paper Hepatic Macrophage Migration Inhibitory Factor Promotes Pancreatic Cancer Liver Metastasis in NAFLD DOI 10.1101/2024.06.02.595997↗
- Ke Lei · 2 shared papers, 2025 · strength 0.51
- Paper HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma DOI 10.2174/1566523223666230720101531↗
- Paper hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.217436↗
- Xianghan Chen · 2 shared papers, 2025 · strength 0.51
- Paper HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma DOI 10.2174/1566523223666230720101531↗
- Paper hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.217436↗
- Chao Gao · 2 shared papers, 2025–2026 · strength 0.42
- Jigang Wang · 2 shared papers, 2024–2025 · strength 0.40
- Boyi Ma · 1 shared paper, 2025 · strength 0.27
- Shunli Fu · 1 shared paper, 2025 · strength 0.24
- Zhan Yang · 1 shared paper, 2025 · strength 0.24
- Huan Zhang · 1 shared paper, 2026 · strength 0.19
- Shanglong Liu · 1 shared paper, 2026 · strength 0.19
- Xiaoya Shi · 1 shared paper, 2026 · strength 0.19
- Qinghui Niu · 1 shared paper, 2026 · strength 0.19
- Jieer Ying · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.